| Malignant pleural mesothelioma: state-of-the-art on current therapies and promises for the future F Nicolini, M Bocchini, G Bronte, A Delmonte, M Guidoboni, L Crinò, ... Frontiers in Oncology 9, 1519, 2020 | 73 | 2020 |
| Induction of G2/M phase arrest and apoptosis by the flavonoid tamarixetin on human leukemia cells F Nicolini, O Burmistrova, MT Marrero, F Torres, C Hernández, J Quintana, ... Molecular carcinogenesis 53 (12), 939-950, 2014 | 64 | 2014 |
| Biomarkers for pancreatic neuroendocrine neoplasms (PanNENs) management—an updated review M Bocchini, F Nicolini, S Severi, A Bongiovanni, T Ibrahim, G Simonetti, ... Frontiers in oncology 10, 831, 2020 | 46 | 2020 |
| Polycomb RING1A-and RING1B-dependent histone H2A monoubiquitylation at pericentromeric regions promotes S-phase progression M Bravo, F Nicolini, K Starowicz, S Barroso, C Calés, A Aguilera, M Vidal Journal of cell science 128 (19), 3660-3671, 2015 | 38 | 2015 |
| ACE2 and TMPRSS2 potential involvement in genetic susceptibility to SARS-COV-2 in cancer patients S Ravaioli, M Tebaldi, E Fonzi, D Angeli, M Mazza, F Nicolini, A Lucchesi, ... Cell transplantation 29, 0963689720968749, 2020 | 28 | 2020 |
| CART-cell therapy: recent advances and new evidence in multiple myeloma M Martino, FA Canale, C Alati, ID Vincelli, T Moscato, G Porto, B Loteta, ... Cancers 13 (11), 2639, 2021 | 22 | 2021 |
| Estrogen and androgen receptor inhibitors: unexpected allies in the fight against COVID-19 S Bravaccini, E Fonzi, M Tebaldi, D Angeli, G Martinelli, F Nicolini, ... Cell Transplantation 30, 0963689721991477, 2021 | 19 | 2021 |
| Lenalidomide enhances CD23. CAR T cell therapy in chronic lymphocytic leukemia S Tettamanti, MC Rotiroti, GMP Giordano Attianese, S Arcangeli, R Zhang, ... Leukemia & lymphoma 63 (7), 1566-1579, 2022 | 15 | 2022 |
| Chimeric antigen receptor T-cell therapy: what we expect soon M Martino, V Naso, B Loteta, FA Canale, M Pugliese, C Alati, G Musuraca, ... International Journal of Molecular Sciences 23 (21), 13332, 2022 | 10 | 2022 |
| Fully human antibodies for malignant pleural mesothelioma targeting F Nicolini, M Bocchini, D Angeli, G Bronte, A Delmonte, L Crinò, M Mazza Cancers 12 (4), 915, 2020 | 5 | 2020 |
| Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors M Bocchini, M Tazzari, S Ravaioli, F Piccinini, F Foca, M Tebaldi, ... Frontiers in Oncology 13, 1136331, 2023 | 3 | 2023 |
| Tamoxifen protects breast cancer patients from COVID-19: first evidence from real world data S Bravaccini, F Nicolini, W Balzi, I Azzali, A Calistri, C Parolin, A Vitiello, ... | 3 | 2021 |
| CAR T cells targeting options in the fight against multiple myeloma. F Nicolini, S Bravaccini, M Mazza, AM Gruszka, M Tazzari, ... Panminerva Medica 63 (1), 37-45, 2020 | 3 | 2020 |
| 126. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection and Vaccination TM Snyder, RM Gittelman, M Klinger, DH May, EJ Osborne, R Taniguchi, ... Open forum infectious diseases 8 (Supplement_1), S77-S77, 2021 | 2 | 2021 |
| An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 … R Maltoni, A Roncadori, W Balzi, M Mazza, F Nicolini, M Palleschi, P Ulivi, ... Biomedicines 12 (3), 498, 2024 | | 2024 |
| Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream L Calabrò, G Bronte, F Grosso, L Cerbone, A Delmonte, F Nicolini, ... Frontiers in Immunology 14, 1333661, 2024 | | 2024 |
| The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic FA Canale, M Martino, G Porto, C Verduci, G Console, G Irrera, B Loteta, ... Supportive Care in Cancer 31 (6), 350, 2023 | | 2023 |
| Why the complications of COVID-19 patients differ in elderly and young cancer patients S Bravaccini, F Nicolini, M Zanoni, A Gaimari, C Cerchione, R Maltoni, ... Translational Oncology 26, 101541, 2022 | | 2022 |
| The Immune System of Mesothelioma Patients: A Window of Opportunity for Novel Immunotherapies F Nicolini, M Mazza Rare Diseases-Diagnostic and Therapeutic Odyssey, 2021 | | 2021 |
| Tamoxifen protects breast cancer patients from COVID-19: first evidence from real world data (preprint) S Bravaccini, F Nicolini, W Balzi, I Azzali, A Calistri, C Parolin, A Vitiello, ... | | 2021 |
